Arrowhead Research | ARWR - 净收入



金融业
股票价格
USD
资产
USD 2.27B
现金及等价物
USD 201.64M
流动资产
USD 1.84B
流动负债
USD 295.22M
债务
USD 312.77M
EBIT
USD -141.26M
EBITDA
USD 57.17M
员工
711
EPS每股收益
USD -0.93
股本和储备
USD 613.98M
销售毛利
USD 264.03M
债务利息支出
USD 22.51M
利息收入
USD 9.69M
贷款资金
USD 1.23B
市值
USD 9.4B
净收入
USD -132.73M
营业费用
USD 215M
营业利润
USD -141.26M
普通股股本
USD 137.39M
PE价格收益
41.67
税前利润
USD 28.27M
销售收入
USD 73.74M
销售和管理费用
USD 41.74M
股票
USD -173.09M
贸易债权人
USD 30.75M
应收帐款人
USD 15.69M


净收入 更改 日
Agios Pharmaceuticals USD -99.11M 8.93M 2026-03
Alnylam Pharmaceuticals USD 205.99M 19.57M 2026-03
Anika Therapeutics USD 292K 2.62M 2025-12
Arrowhead Research USD -132.73M 163.54M 2026-03
Heron Therapeutics USD -2.95M 14.54M 2025-12
Incyte USD 303.33M 4.05M 2026-03
Ionis Pharmaceuticals USD -93M 136M 2026-03
Ligand Pharmaceuticals USD -13.34M 58.13M 2026-03
Merck USD -4.24B 7.2B 2026-03
Moderna USD -1.34B 517M 2026-03
Nektar Therapeutics USD -36.08M 978K 2025-12
Novartis USD 3.16B 747M 2026-03
Sarepta Therapeutics USD 330.96M 743.18M 2026-03
TG Therapeutics USD 19.78M 3.26M 2026-03
Ultragenyx Pharmaceutical USD -185M 56M 2026-03
Vertex Pharmaceuticals USD 1.03B 159.7M 2026-03
Xencor USD -128.92M 122.26M 2026-03